Related Experiment Videos
Steroid refractory interstitial pneumonitis in a patient with juvenile dermatomyositis
Yu-Chuan Lin1, Yao-Hsu Yang, Yu-Tsan Lin
1Taipei Municipal Women's and Children's Hospital, Taipei, Taiwan, ROC.
Insights
Interstitial pneumonitis is a severe complication in juvenile dermatomyositis. This case highlights a challenging pediatric presentation unresponsive to aggressive therapies, emphasizing diagnostic vigilance.
Area of Science:
- Pediatric Rheumatology
- Pulmonology
- Medical Histopathology
Background:
- Juvenile dermatomyositis (JDM) is an idiopathic inflammatory myopathy affecting children.
- Interstitial pneumonitis (IP) represents a serious, potentially fatal complication of JDM.
- Early recognition and treatment are crucial for managing JDM-associated IP.
Observation:
- A 4-year-old girl with JDM presented with respiratory symptoms including cough and dyspnea.
- Histopathology confirmed interstitial pneumonitis despite normal creatinine phosphokinase levels.
- The patient's condition did not improve with standard aggressive treatments like pulse steroids, IVIG, and cyclosporine.
Findings:
- The case illustrates a refractory interstitial pneumonitis in a pediatric patient with juvenile dermatomyositis.
- Normal muscle enzyme levels (creatinine phosphokinase) can occur in JDM patients with IP.
- Aggressive immunosuppressive regimens showed limited efficacy in this severe presentation.
Implications:
- Highlights the critical need for a high index of suspicion for interstitial pneumonitis in JDM patients presenting with respiratory symptoms.
- Underscores the importance of considering IP in the differential diagnosis of respiratory distress in pediatric rheumatology patients.
- Suggests potential for novel therapeutic strategies for refractory JDM-associated interstitial pneumonitis.
Abstract:
Interstitial pneumonitis is a severe complication of juvenile dermatomyositis. We report a 4-year-old girl with juvenile dermatomyositis. Coughing, shortness of breath, and general malaise developed during steroid treatment. The histology of her lung biopsy is compatible with interstitial pneumonitis. Aggressive treatment including intravenous methylprednisolone pulse therapy, intravenous immunoglobulin, and oral cyclosporin all failed. Creatinine phosphokinase level was within the normal range during the disease course. The clinical features are discussed and the importance of a differential diagnosis of interstitial pneumonitis in patients with juvenile dermatomyositis is emphasized.